Erratum: Author correction to "PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD/ENO1 mediated cell metabolism" Acta Pharm Sin B 13 (2023) 157-173.
- Author:
Mingming SUN
1
;
Leilei LI
2
;
Yujia NIU
3
;
Yingzhi WANG
1
;
Qi YAN
1
;
Fei XIE
1
;
Yaya QIAO
1
;
Jiaqi SONG
1
;
Huanran SUN
1
;
Zhen LI
2
;
Sizhen LAI
4
;
Hongkai CHANG
1
;
Han ZHANG
1
;
Jiyan WANG
1
;
Chenxin YANG
4
;
Huifang ZHAO
4
;
Junzhen TAN
4
;
Yanping LI
5
;
Shuangping LIU
6
;
Bin LU
7
;
Min LIU
8
;
Guangyao KONG
9
;
Yujun ZHAO
10
;
Chunze ZHANG
11
;
Shu-Hai LIN
3
;
Cheng LUO
10
;
Shuai ZHANG
4
;
Changliang SHAN
1
Author Information
- Publication Type:Published Erratum
- From: Acta Pharmaceutica Sinica B 2025;15(4):2297-2299
- CountryChina
- Language:English
- Abstract: [This corrects the article DOI: 10.1016/j.apsb.2022.05.019.].
